SocialPicks Sentiment:
** v.s.
other stocks
|
This Quarter's Sentiment:
|
|
|
MDT Analysis & Videos »
MDT: Bull or Bear?
Dividend growth trio: Aflac, Medtronic and Colgate-Palmolive
MDT
+17.49%
in
33 days
Filed under: Newsletters, AFLAC Inc (AFL), Colgate-Palmolive (CL), Stocks to Buy  "One way to build an inflation hedge into your investment cash flows is to focus on stocks that are likely to boost their dividends on a regular basis," explains dividend specialist Chuck Carlson.
<>In his The DRIP Investor, which focuses on blue chip companies offering dividend reinvestment programs, he notes, "Since dividends are paid with cold cash, they can't be faked. Either you pay the dividend or you don't. They can't be some figment of accounting magic." Here, he looks at three favorite blue chips with stro...
|
FDA Calendar Updates: ARDM, BFRM, CRTX, MDT, Zogenix
MDT
|
|
|
+24.37%
in
144 days
<> Below is a summary of updates to the <font> BioMedReports.com FDA Calendar </font> , which includes a database of 260 entries as of 7/16/09. The calendar was originally created by Mike Havrilla to track companies with pending new drug, biological agent, or medical device new product decisions at the FDA. With the launch of <font> BioMedReports.com </font> , the FDA Calendar has expanded to include the following categories: pending new submissions to the FDA (e.g. NDA, BLA, 510k, PMA, sNDA, sBLA filings), pending complete response letter (CRL) re-submissions to the FDA, and pendin...
|
Medtronic: A great play on an aging population
MDT
+26.16%
in
291 days
Filed under: Earnings reports, Stocks to Buy  Shares of medical device maker Medtronic Inc. (NYSE: MDT) surged on Tuesday in an otherwise lousy market after the company said tighter cost controls and new demand for spinal implants helped it exceed Wall Street's expectations. Shares have been slipping, however, since Tuesday, from a high of $35.39 to $34.44 mid-morning Thursday.
For the quarter Medtronic earned $723 million, or 65 cents per share, on revenue of $3.49 billion. <>After adjusting for in-process research and development charges of $72 million, or 6 cents per share, non-GAAP net earnin...
|
Chasing Value: Feds single source Intuitive Surgical
MDT
|
|
|
+35.34%
in
383 days
Filed under: International markets, Press releases, Products and services, Competitive strategy, Johnson and Johnson (JNJ), Chasing Value, Stocks to Buy, Intuitive Surgical Inc (ISRG), Technology  Yesterday, in response to Chasing Value: ISRG is falling and I'm buying I received the following comment from Beltway Greg, "You're a brave dude. Why? I've watched this stock for awhile and I worry about possible entry by other folks into the market."
Brave perhaps, even foolish on occasion, but I still think this is the time to be selectively buying equities. <>To those that might be concerned about co...
|
ETFI Health Innovators Index: Does R&D Lead to Higher Stock Prices?
MDT
|
|
|
-9.07%
in
245 days
(closed on 07/16/09)
<> 
<> The accompanying table includes statistics and the top five rated companies in the ETFI Global Health Innovators Index of companies with market caps over $100M which received FDA approval in the trailing 12-month period for either an original new drug or medical device product. The index includes companies which get approvals for drugs or biological agents classified as new chemical entities (i.e. excluding reformulations of existing drugs, generic drugs, and label extensions for existing produc...
|
Expanding Defensive Growth Index into Europe
MDT
|
|
|
-4.05%
in
20 days
(closed on 11/12/08)
<> 
<> The accompanying table presents an updated version of the ETFI Highly Defensive PerformIdex, which is expanded to 40 companies with market caps of at least $10B from the industry groups listed below. This defensive growth index is heavily weighted in consumer staples and healthcare and is now structured to include companies based in Europe, in addition to the United States and Canada.
Compared to the previous version, this index has a lower beta and higher average market cap and adds European companie...
|
Medtronic (MDT): Shares define bullish flag
MDT
-13.43%
in
557 days
Filed under: Earnings reports, Analyst upgrades and downgrades, Johnson and Johnson (JNJ), Boston Scientific (BSX), Technical Analysis, Stocks to Buy <>Medtronic (NYSE: MDT) is a medical technology company, specializing in a variety of implantable biomedical devices. Leading products include pacemakers, stents, catheters, glucose monitoring systems and insulin pumps. The firm's Cardiac Surgery segment offers products for the repair and replacement of heart valves, surgical accessories, and surgical ablation products. A Physio-Control unit provides external defibrillation and emergency response...
|
People Bullish on MDT
People Bearish on MDT
|
ROCK-STAR INVESTORS
|
|
POPULAR STOCKS
|
|
TODAY'S HEADLINES
|
|
TODAY'S TOP PICKS
|
|
|
Portfolio results thru 8/8/08
- Portfolio at www.updown.com - started 1/11/08
9.8% return includes dividends and commission.
Started socialpicks on 6/30. some stocks here are not in...
|
Stock update and watch list 7/29/08
- Due to difficulties understanding the socialpicks system regarding changing rating from buy to hold and thus resetting the performance, I wanted to sum...
|
More Resources
|
About Medtronic Inc
- Answers.com
